These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
238 related items for PubMed ID: 14506367
1. Hyperlactatemia in human immunodeficiency virus-infected children receiving antiretroviral treatment. Noguera A, Fortuny C, Sanchez E, Artuch R, Vilaseca MA, Muñoz-Almagro C, Pou J, Jiménez R. Pediatr Infect Dis J; 2003 Sep; 22(9):778-82. PubMed ID: 14506367 [Abstract] [Full Text] [Related]
2. A high incidence of lactic acidosis and symptomatic hyperlactatemia in women receiving highly active antiretroviral therapy in Soweto, South Africa. Bolhaar MG, Karstaedt AS. Clin Infect Dis; 2007 Jul 15; 45(2):254-60. PubMed ID: 17578788 [Abstract] [Full Text] [Related]
3. Lactic acidemia in human immunodeficiency virus-uninfected infants exposed to perinatal antiretroviral therapy. Alimenti A, Burdge DR, Ogilvie GS, Money DM, Forbes JC. Pediatr Infect Dis J; 2003 Sep 15; 22(9):782-9. PubMed ID: 14506368 [Abstract] [Full Text] [Related]
4. Hyperlactatemia in human immunodeficiency virus-uninfected infants who are exposed to antiretrovirals. Noguera A, Fortuny C, Muñoz-Almagro C, Sanchez E, Vilaseca MA, Artuch R, Pou J, Jimenez R. Pediatrics; 2004 Nov 15; 114(5):e598-603. PubMed ID: 15492359 [Abstract] [Full Text] [Related]
8. Serum lactate levels in infants exposed peripartum to antiretroviral agents to prevent mother-to-child transmission of HIV: Agence Nationale de Recherches Sur le SIDA et les Hépatites Virales 1209 study, Abidjan, Ivory Coast. Ekouevi DK, Touré R, Becquet R, Viho I, Sakarovitch C, Rouet F, Towne-Gold B, Fassinou P, Leroy V, Blanche S, Dabis F, Agence Nationale de Recherches Sur le SIDA 1201/1202 Ditrame Plus Study Group. Pediatrics; 2006 Oct 15; 118(4):e1071-7. PubMed ID: 16950945 [Abstract] [Full Text] [Related]
9. Symptomatic hyperlactatemia associated with nucleoside analogue reverse-transcriptase inhibitor use in HIV-infected patients: a report of 24 cases in a resource-limited setting (Uganda). Songa PM, Castelnuovo B, Mugasha EB, Ocama P, Kambugu A. Clin Infect Dis; 2007 Aug 15; 45(4):514-7. PubMed ID: 17638205 [Abstract] [Full Text] [Related]
10. Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort Study. Boubaker K, Flepp M, Sudre P, Furrer H, Haensel A, Hirschel B, Boggian K, Chave JP, Bernasconi E, Egger M, Opravil M, Rickenbach M, Francioli P, Telenti A. Clin Infect Dis; 2001 Dec 01; 33(11):1931-7. PubMed ID: 11692306 [Abstract] [Full Text] [Related]
11. Hyperlactataemia in HIV-infected patients: the role of NRTI-treatment. Vrouenraets SM, Treskes M, Regez RM, Troost N, Smulders YM, Weigel HM, Frissen PH, Brinkman K. Antivir Ther; 2002 Dec 01; 7(4):239-44. PubMed ID: 12553477 [Abstract] [Full Text] [Related]
13. Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients. Côté HC, Brumme ZL, Craib KJ, Alexander CS, Wynhoven B, Ting L, Wong H, Harris M, Harrigan PR, O'Shaughnessy MV, Montaner JS. N Engl J Med; 2002 Mar 14; 346(11):811-20. PubMed ID: 11893792 [Abstract] [Full Text] [Related]
17. Influence of antiretroviral therapy on oxidative stress and cardiovascular risk: a prospective cross-sectional study in HIV-infected patients. Masiá M, Padilla S, Bernal E, Almenar MV, Molina J, Hernández I, Graells ML, Gutiérrez F. Clin Ther; 2007 Jul 14; 29(7):1448-55. PubMed ID: 17825696 [Abstract] [Full Text] [Related]
19. Mutations linked to drug resistance, human immunodeficiency virus type 1 biologic phenotype and their association with disease progression in children receiving nucleoside reverse transcriptase inhibitors. Englund JA, Raskino C, Vavro C, Palumbo P, Ross LL, McKinney R, Nikolic-Djokic D, Colgrove RC, Baker CJ, Pediatric AIDS Clinical Trials Group Protocol 152 Team. Pediatr Infect Dis J; 2004 Jan 14; 23(1):15-22. PubMed ID: 14743040 [Abstract] [Full Text] [Related]